1313816-86-2

Upstream product

• 1313816-85-1 t-butyl 3-[N-(benzyloxycarbonyl)-N-(methyl)aminomethyl]-2-azabicyclo[3.1.0]hexane-2-carboxylate 
• 1313816-84-0 3-methylaminomethyl-2-azabicyclo[3.1.0]hexane-2-carboxylic acid tert-butyl ester 
• 1313816-83-9 3-methanesulfonyloxymethyl-2-azabicyclo[3-1.0]hexane-2-carboxylic acid tert-butyl ester 
• 1309077-14-2 3-hydroxymethyl-2-azabicyclo[3.1.0]hexane-2-carboxylic acid tert-butyl ester 
• 1309077-13-1 3-(tert-butyldiphenylsilanyloxymethyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic acid tert-butyl ester 
• 501-53-1 benzyl chloroformate 

Downstream Products

• 1313816-93-1 furan-2-yl-[3-[(N-benzyloxycarbonyl-N-methyl)aminomethyl]-2-azabicyclo[3.1.0]hex-2-yl]methanone 

Relevant academic research and scientific papers

Alpha 4 Beta 2 NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS

The present invention relates to novel α4β2 neuronal nicotinic acetylcholine receptor ligand compounds of the formula (I), and their derivatives, stereoisomers, pharmaceutically acceptable salts and compositions containing them. The

α4β2 NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS

The present invention relates to novel α4β2 neuronal nicotinic acetylcholine receptor ligand compounds of the formula (I), and their derivatives, stereoisomers, pharmaceutically acceptable salts and compositions containing them. The